Company / Operating Cash Flow
TransMedics Group, Inc. Operating Cash Flow History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$192.8M
FY2025
5-year range
-$30.3M / $192.8M
FY2021-FY2025
Trend
+295.1%
vs FY2024
Sector context
#87 of 164
Health Care
What the data says
Operating Cash Flow changed +295% YoY in FY2025, a notable deviation from the 7-year average annual change of +116%.
Based on SEC 10-K filings.
$193M in FY2025.
Improved from -$13M to $193M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#87 of 164 in Health CareTop 53% of 164This company $192.8M Sector average $1.0B
▼
-81.5% below sector average
Key checks
Key Insights
- TransMedics Group, Inc.'s operating cash flow has grown for 3 consecutive years.
- In FY2025, operating cash flow increased 295.1% year-over-year.
- Ranks #87 out of 164 companies in the Health Care sector.
- Lowest operating cash flow in the period was in FY2020.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $192.8M | +295.1% |
| FY2024 | $48.8M | +474.6% |
| FY2023 | -$13.0M | +57.0% |
| FY2022 | -$30.3M | +0.0% |
| FY2021 | -$30.3M | +6.3% |
| FY2020 | -$32.3M | -24.3% |
| FY2019 | -$26.0M | +0.0% |
| FY2018 | -$26.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026